Due to the growing demand of our global business and the drive to deliver innovative diagnostic services, we are proud to announce the launch of our new business unit, Viroclinics Xplore.
To enable and assist our clients with a hassle-free submission process, it was decided to contract Zwiers Regulatory Consultancy as our main strategic regulatory partner.
In this case study article Viroclinics Biosciences‘ team member Saskia Smits sheds light on a customized research model, designed to tackle the challenge of typing multiple Rhino- and Enteroviruses.
An interview with lead author Penelope Koraka, sharing her latest insights on Rabies, recently published in Frontiers in Microbiology.
The French ministry of research and innovation approves Viroclinics Biosciences as an intermediate vendor for The French Tax Credit Incentive (Crédit d’Impôt Recherche or CIR), a tax relief measure for companies focused on Research & Development activities.
Subscribe to our newsletter for the latest insights on early stage, (pre)clinical research, cold chain logistics and assay development services.